CONTENTS:
- Cannabis research in context: The case for measuring and embracing regional similarities and differences [Editorial]. Cousijn J., Kuhns L., Filbey F., Freeman T.P., Kroon E., p. 1502-1504.
- Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks? [Addiction opinion and debate]. Khazanov G.K., McKay J.R., Rawson R., p. 1505-1514.
- Contingency management as a maintenance intervention in the long-term treatment of substance use disorders. Toegel F., Toegel C., Silverman K., p. 1515-1516.
- Virtual contingency management, what is it worth and who will pay for it? McKetin R., Clay S., p. 1517-1518.
- Closing the research-to-implementation gap for contingency management as an effective intervention for substance use disorders across diverse communities. Hirchak K., p. 1519-1521.
- Contingency management needs implementation science. Becker S.J., p. 1522-1524.
- Research is needed to guide contingency management implementation across populations and settings. Rawson R., Khazanov G.K., McKay J.R., p. 1525-1526.
- Alcohol use and alcohol use disorders in sub-Saharan Africa: A systematic review and meta-analysis. Belete H., Yimer T.M., Dawson D., Espinosa D.C., Ambaw F., Connor J.P., et al., p. 1527-1540.
- Commentary on Belete et al.: Alcohol use prevalence findings for sub-Saharan Africa can be better understood when coupled with a deep appreciation of the continent's diverse cultural contexts and drinking patterns. Morojele N.K., p. 1541-1542.
- Classifying national drinking patterns in Europe between 2000 and 2019: A clustering approach using comparable exposure data. Correia D., Manthey J., Neufeld M., Ferreira-Borges C., Olsen A., Shield K., et al., p. 1543-1553.
- The association between alcohol retail access and health care visits attributable to alcohol for individuals with and without a history of alcohol-related health-care use. Myran D.T., Friesen E., Talarico R., Gaudreault A., Taljaard M., Hobin E., et al., p. 1554-1563.
- A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia. Darke S., Duflou J., Peacock A., Farrell M., Hall W., Lappin J., p. 1564-1571.
- Commentary on Darke et al.: Expanded psychedelic access requires new safety monitoring systems. Korthuis P.T., Wilson-Poe A.R., Black J.C., Monte A., p. 1572-1574.
- Increased cancer incidence and mortality among people with opioid use-related disorders: A nation-wide cohort study. Kostovski E., Hamina A., Hjellvik V., Clausen T., Skurtveit S., p. 1575-1584.
- The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine. Ivasiy R., Madden L.M., Meteliuk A., Machavariani E., Ahmad B., Zelenev A., et al., p. 1585-1596.
- Young adults with a history of substance use disorder experienced more negative mental health, social and economic outcomes during the COVID-19 pandemic period. Halvorson M.A., Kuklinski M.R., Bailey J.A., Caouette J.D., Guttmannova K., Rhew I.C., et al., p. 1597-1607.
- Quitting intentions and behaviours among young Australian e-cigarette users. Jongenelis M.I., Gill M., Lawrence N., Wakefield C.E., p. 1608-1615.
- Effect of a peer-led prevention program (P2P) on smoking in vocational high school students: Results from a two-school-year cluster-randomized trial. Lareyre O., Cousson-Gélie F., Pereira B., Stoebner-Delbarre A., Lambert C., Gourlan M., p. 1616-1628.
- Incident psychotic experiences following self-reported use of high-potency cannabis: Results from a longitudinal cohort study. Hines L.A., Heron J., Zammit S., p. 1629-1634.
- Web-based intervention for young adults experiencing anxiety and hazardous alcohol use: Study protocol for an 18-month randomized controlled trial. Prior K., Baillie A.J., Newton N., Lee Y.Y., Deady M., Guckel T., et al., p. 1635-1647.
- Changes in self-reported cannabis use in the United States from 1979 to 2022. Caulkins J.P., p. 1648-1652.
- Addiction Lives: Maggie Brady. Berridge V., p. 1653-1654.
- Para-fluorofentanyl: Coincidence or intentional? Canfield J.R., Canfield K.V., Sprague J.E., p. 1655-1656.
- The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks. Killeen N., Lakes R., Webster M., Killoran S., McNamara S., Kavanagh P., et al., p. 1657-1658.
- Navigating the digital age: The need for online-specific gambling marketing regulations. Rossi R., Nairn A., p. 1659-1660.